Lantheus Holdings Announces Presentations Featuring PYLARIFY® (Piflufolastat F 18), its PSMA-Targeted Prostate Cancer Imaging Agent, at Key Scientific Meetings
17 nov. 2021 08h30 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...
Lantheus Holdings to Present at the 4th Annual Evercore ISI HealthCONx Conference
16 nov. 2021 16h30 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging...
Lantheus Holdings, Inc. Reports Third Quarter 2021 Financial Results
04 nov. 2021 07h00 HE
|
Lantheus Holdings, Inc.
Worldwide revenue of $102.1 million for the third quarter 2021, representing an increase of 15.3% from the prior year periodGAAP net loss of $13.4 million for the third quarter 2021, compared to GAAP...
Lantheus Holdings to Present at Upcoming Investor Conferences
28 oct. 2021 16h30 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging...
Lantheus Holdings to Host Third Quarter 2021 Earnings Conference Call and Webcast on November 4, 2021 at 8:00 a.m. Eastern Time
21 oct. 2021 08h00 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on...
Lantheus Announces Addition of PSMA PET Imaging Agent to the National Comprehensive Cancer Network® (NCCN) Guidelines for Prostate Cancer
13 sept. 2021 08h00 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...
Lantheus and RefleXion Announce Development and Commercialization Collaboration with the Potential to Improve Future Prostate Cancer Treatment
13 sept. 2021 07h30 HE
|
Lantheus Holdings, Inc.; RefleXion Medical, Inc.
NORTH BILLERICA, Mass. and HAYWARD, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) and RefleXion Medical, Inc., today announced a development and...
Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting
10 sept. 2021 08h30 HE
|
Lantheus Medical Imaging
Highlights Piflufolastat F 18’s Potential to Change Initial Risk Assessment and Intended Patient Management in High-Risk Prostate Cancer Identified Regional Lymph Node and/or Distant Metastases in...
Lantheus Holdings to Present at Upcoming Investor Conferences
02 sept. 2021 08h00 HE
|
Lantheus Medical Imaging
NORTH BILLERICA, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging...